Ambra Thomas e. D PhD

Ambra Thomas e. D PhD discloses dealings in Albany Molecular Research Inc to SEC (Form 4). We count 41 filings; the first trade dates from 25 May 2006 and the latest from 10 June 2015.

Both buying and selling appear: 1 purchase worth €30k, against 16 sales worth €3.7M. On balance, insiders were net sellers of €3.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants. In 2015 alone, the filings show no purchases and 6 sales.

Most recently, on 11 June 2015, the filings show an open-market sale worth €350k in Albany Molecular Research Inc. The latest purchase dates back some time: it was published 5,103 days ago, on 19 November 2012. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.